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5MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UKAbstractEMSY interacts directlywith BRCA2 and links the BRCA2 pathway to sporadic breast and ovarian cancer.
It also interacts with BS69 and HP1b, both of which are involved in chromatin remodelling, and with
NIF-1 and DBC-1 in the regulation of nuclear receptor-mediated transcription. Here we investigate the
function of EMSY during amphibian development, and in doing so provide the first loss-of-function
analysis of this protein. Injection of Xenopus tropicalis embryos with antisense morpholino
oligonucleotides targeting XtEMSY impairs gastrulationmovements, disrupts dorsal structures, and kills
embryos by tailbud stages. Consistent with these observations, regional markers such as Xbra, Chd,Gsc,
Shh, Sox3 and Sox17 are downregulated. In contrast to these regional markers, expression of p53 is
upregulated in such embryos, and at later stages Bax expression is elevated and apoptotic cells can be
detected. Our results demonstrate that EMSYhas an essential role in development and they provide an in
vivo loss-of-function model that might be used to explore the biochemical functions of this protein in
more detail.Introduction
The EMSY protein is upregulated in breast and ovarian cancers
[1]. The N-terminal region of the protein interacts with the
transactivation domain of BRCA2 and with the chromatin mod-
elling-associated proteins BS69 and HP1b [1]. This region defines
an evolutionarily conserved ENT (EMSY N-Terminus) domain
that is represented in plants as well as in animals, although EMSY
is the only known ENT-containing protein in the human pro-
teome [1,2]. More recently EMSY has been shown to participate
in a complex with NIF-1 and DBC-1 in the regulation of nuclear
receptor-mediated transcription [3]. Finally, EMSY co-localises at
g-H2AX foci following radiation-induced double-strand DNA
breaks in mouse embryonic fibroblasts, suggesting that it mayCorresponding author: Smith, J.C. (director@nimr.mrc.ac.uk)
6 These authors contributed equally to this work.
334 www.elsevier.com/locate/nbt 18also have a role in DNA damage repair [1]. Indeed, over-expres-
sion of a truncated from of EMSY results in chromosomal
instability, although this construct was expressed at levels ten
times higher than those in naturally occurring tumours [4].
Thus, in adult cells EMSY is implicated in a variety of cellular
processes including gene transcription, chromatin remodelling,
and DNA repair.
In this study, in an effort to gain further insights into the
functions of EMSY, we address its role during early development,
and in so doing provide the first loss-of-function analysis of EMSY.
The Xenopus tropicalis genome contains a gene that is highly
homologous to mammalian EMSY (XtEMSY). A ‘short’ form of
XtEMSY is expressed throughout early development and is co-
expressed with mRNAs encoding interacting proteins such as
BRCA2, BS69 andHP1b. Use of antisensemorpholino oligonucleo-
tides directed against XtEMSY disrupts gastrulation and causes a71-6784 2010 Elsevier B.V. doi:10.1016/j.nbt.2010.10.010Open access under CC BY license.
New Biotechnology Volume 28, Number 4  July 2011 RESEARCH PAPERdownregulation of genes including Gsc and Shh. At later stages we
observe an upregulation of p53, which may underlie the elevated
levels of apoptosis we observe and, through its ability to interact
with the TGF-b signal transduction pathway (5), may exacerbate
the defects in embryonic patterning.
Materials and methods
Embryos and in vitro fertilization
Embryo generation and manipulation were carried out as
described [5].[()TD$FIG]
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FIGURE 1
Genomic structure of the XtEMSY locus and of XtEMSY isoforms. The XtEMSY locus co
A short transcript comprising exons 1–7 and exon 22, encoding a protein of 269
representing this transcript were found in egg, gastrula and tadpole cDNA libraries
(tadpole). The short and the long forms of XtEMSY both contain the ENT domainMO design and microinjection
Antisense morpholino oligonucleotides (MOs) were obtained from
GeneTools. Embryos were injected with 15 ng antisense morpho-
lino oligonucleotides at a concentration of 10 ng/nl in water. MOs
had the following sequences. XtEMSYMO1: 50-CCACACCACCGG-
CATCCTGGCCTCT-30; XtEMSY mMO1: 50-CCACACCACCGG-
CATCCTGGCCTCT-30, XtEMSY MO2: 50-TGGCCTCTCCTCCA-
CAGAGCGCCCT-30; XtEMSY mMO2: 50-TGGCCTCTCCTCCACA-
GAGCGCCCT-30; Xtp53MO: 50-GCCGGTCTCAGAAGAAGGTCC-
CATG-30.H
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mprises 22 exons, of which the first 21 encode a protein of 1291 amino acids.
amino acids, was detected in early embryos of Xenopus tropicalis. ESTs
: AL870737.2 (egg); AL871852.2 (egg); AL652745.2 (gastrula); and CX371164.1
and putative HP1b and BS69 binding sites.
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FIGURE 2
Expression of XtEMSY during development. RT-PCR confirms that the long
form of XtEMSY is expressed in adult brain and testis (a), and that the short
form is expressed at the 2-cell stage and at embryonic stages 8.5, 10.5, 13, 18,
24 and 40 (b). Primers specific for EF1a were used as a control.
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RNA extraction was carried out using TRIZOL reagent (Invitrogen)
according to themanufacturer’s instructions (except that RNAwas
LiCl precipitated a second time at the end of the protocol). cDNA
synthesis was carried out using SuperscriptII (Invitrogen) and
random hexamer primers. The following primers were used in
RT-PCR: XtEMSY forward: 50-GCCAGGATGCCGGTGGTG-30;
reverse: 50-GCGTTTATTCCAGGGATCCTCTG-30. EF1a forward:
50-TGGACACGTAGATTCTGG-30; reverse: 50-CAGCAACAATCAG-
GACAG-30.
In situ hybridisation
Wholemount in situ hybridisation was carried out as described [6],
using DIG-labelled probes and BM purple (Roche) as substrate.
Full-length probes were generated from the following cDNAs, in
pCS107, picked from the Gurdon Institute X. tropicalis cDNA
collection. They were digested with EcoRI and transcribed with
T7 RNA polymerase. Xbra: Tgas071i19; Chd: Tgas143n13; EMSY:
Tgas029a21; Gsc: Tneu077f20; p53: Tneu034a23; Rad51:
Tegg126n13; Shh: Tneu023n04; Sox3: Tgas079n14; Sox17a:
Tgas079e22.
TUNEL staining
TUNEL staining was carried out as described [7].
Real-time RT-PCR
Real-timeRT-PCRwasperformedusingaRocheLightcycler 480.The
following primer pairs were used: ODC forward: 50-GCCATCGT-
GAAGACTCTCTCCC-30; reverse: 50-TTCGGGTGATTCCTTGCCAC-
30. p53 forward: 50-AAACTTTGCGGAGTTTTCAGAG-3; reverse: 50-
GGTGGAGTATGTGCAGGTAACA-30. Bax forward: 50-GAGCC-
TTGGTGCTGCAGGGG-30; reverse: 50-GGAGCCTGGGAATA-
GCGCCC-30. Xbra forward: 50-ATCAAACACAACCCCTTTGC-30;
reverse: 50-CGAGCGGTGGTTTCTTAGAG-30. Chd forward: 50-
AACTGCCAGGACTCATGGATG-30; reverse: 50-GGCAGGATTTA-
GAGTTGCTTC-30. Gsc forward: 50-GTTTTCAGCCAGGAGAGA-
GAGA 30; reverse: 50-ATGTTGTCAATGCTGAACATGC-30. Shh
forward: 50-AGCCTTTGATGTAATTGGCTTC-30; reverse: 50-AATC-
TTTCCTTCGTATCGACCA-30.
Results
Identification of Xenopus EMSY
To identify the Xenopus orthologue of human EMSY we performed
sequence searcheswith the full-lengthhumanEMSYsequenceusing
the University of California Santa Cruz (UCSC) genome browser
(http://genome.ucsc.edu/index.html?org=X.+tropicalis&db=xen
Tro2&hgsid=129491895), the X. tropicalis full-length EST database
(http://informatics.gurdon.cam.ac.uk/online/xt-fl-db.html) [8],
and EST databases at NCBI (http://www.ncbi.nlm.nih.gov) [9,10].
We thus identified an X. tropicalis locus that is orthologous to
human EMSY on scaffold_609 between positions 307237 and
325312. Our analysis of the X. tropicalis EMSY locus indicates that
it consists of 22 exons, the first 21 ofwhich are predicted to generate
a protein of 1291 amino acids which is 78% identical to its 1322
amino acid human orthologue (Fig. 1a). Our X. tropicalis EST data-
base searches, however, identifiedonlya transcript that corresponds
to exons 1–7 and exon 22, and which encodes a protein of 269
aminoacids (Fig. 1b). This protein is 94% identical to aminoacids1–336 www.elsevier.com/locate/nbt255 of human EMSY and it contains the ENT domain, which
interacts with BRCA2, as well as the HP1b and BS69 binding sites,
making it possible that the protein is involved in transcriptional
regulation, chromatin modification and DNA repair. Our PCR ana-
lysis (below) confirms that this transcript is expressed in the early
Xenopus embryo, and we note that an EST encoding a 299 amino
acid protein is also present in a cow EST library.
Expression of Xenopus tropicalis EMSY
Although we have only been able to identify a short form of
XtEMSY from database searches, RT-PCR analysis reveals that a
full-length version is expressed in adult tissues such as testis and
brain (Fig. 2a). The short form is expressed in the embryo at least
from the 2-cell stage to tadpole stage 40, and there is a significant
upregulation at early gastrula stage 10 (Fig. 2b). Whole mount in
situ hybridisation experiments, using a probe complementary to
the short form of XtEMSY, showed that at gastrula stages expres-
sion is widespread through the ectoderm and that at later stages it
is strongest in anterior dorsal tissues such as anterior neural
epithelium, head, neural tube and somites (Fig. 3a–h).
XtEMSY mRNA is co-expressed with RNA encoding potential
interacting proteins
EMSY interacts with various proteins involved in transcriptional
regulation, chromatin modification and DNA repair, including
BRCA2, BS69, ETS-2 and HP1b [1]. Transcripts encoding the X.
tropicalis orthologues of these proteins proved to have similar
expression patterns to XtEMSY during early development
(Fig. 3i–x), defining them as members of a synexpression group
[5]. This observation is consistent with the possibility that XtEMSY
interacts with the same proteins as its mammalian counterpart,
and that it plays the same roles as the mammalian protein.
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FIGURE 3
Analysis of the expression of XtEMSYand of some of its putative interactors. Gastrula stages are shown in panels (a, e, i,m, q, u), neurula stages in panels (b, f, j, n,
r, v), tailbud stages in panels (c, g, k, o, s, w) and tadpole stages in panels (d, h, l, p, t, x). (a–d) Use of an XtEMSY sense probe shows no staining. (e–h) XtEMSY is
expressed throughout the ectoderm at the gastrula stage (e) and is then expressedmost strongly in the neural plate and dorsal regions at the neurula stage (f ). By
tailbud stages XtEMSY is expressed most strongly in the head and along the dorsal axis (g). At tadpole stage XtEMSY staining is observed in the entire head region,
including the brain, eye, otic vesicle and branchial arches and along the dorsal axis in the neural tube and somites (h). The expression patterns of BRCA2 (i–l), BS69
(m–p), Ets-2 (q–t) and HP1b (u–x) resemble those of XtEMSY.
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Although over-expression of a truncated form of human EMSY in
184-hTert cells causes chromosomal abnormalities [4], we saw no
effect of over-expression of up to 1.2 ng wild type XtEMSY RNA
(the short form) in X. tropicalis embryos (data not shown). This
apparent discrepancy may derive from differences between trun-
cated human EMSY and the short form of XtEMSY, from differ-ences between in vitro and in vivo systems, or from differences
between adult and embryonic cells.
In an effort to inhibit XtEMSY function, we turned to antisense
morpholino oligonucleotides (MOs) [5,11,12]. We used two inde-
pendent MOs designed to inhibit translation of XtEMSY (XtEMSY
MO1 and XtEMSY MO2), and as controls we made use of the
GeneTools control MO as well as MOs carrying five base mis-www.elsevier.com/locate/nbt 337
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FIGURE 4
Loss of XtEMSY function causes defects in gastrulation and neurulation. Embryos injected with GeneTools control MO develop normally (a and b), whereas those
injected with XtEMSY MO1 (c and d) or XtEMSY MO2 (g and f) fail to gastrulate normally and form a truncated axis. (g–o) Embryos injected with antisense
morpholino oligonucleotides carrying five bases mismatches do not perturb development. (g–i) Uninjected embryos at gastrula, neurula and tailbud stages. (j–l)
Embryos at the same stages injected with XtEMSY mMO1, and (m–o) show embryos injected with XtEMSY mMO2. (p–y) A time course experiment shows that in
comparison with controls (p–t) embryos injected with XtEMSY MO1 (u–y) first show abnormalities at the early gastrula stage (compare q and v).
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and XtEMSY mMO2). Both specific MOs yielded a phenotype that
was characterised by a delay in the onset of gastrulation and then
by defects in head and axial development (Fig. 4c–f), followed by
death at tailbud stages (data not shown). None of the three control
MOs caused a detectable disruption of development (Fig. 4a,b,j–
l,p–t). Because both MOs directed against XtEMSY yielded the
same phenotype, we henceforth present data using only XtEMSY
MO1 unless otherwise stated.
Our attempts to rescue the XtEMSYMO phenotype by injection
ofmRNA encoding the short formof XtEMSY did not succeed (data
not shown). It is possible that injected mRNA does not spread
rapidly enough throughout the embryo, or that XtEMSY protein is
unstable and does not persist to the appropriate stages.
Analysis of early patterning markers during gastrula and tailbud
stage
Antisense MOs directed against XtEMSY cause a delay in gastrula-
tion followed by a disruption of neurulation and of further devel-
opment. To understand the molecular basis of this phenotype, we338 www.elsevier.com/locate/nbtused whole mount in situ hybridisation to examine the expression
of genes including Xbra (expressed in mesoderm), Chordin (Chd:
chordamesoderm), Goosecoid (Gsc: dorsal mesendoderm), Sonic
hedgehog (Shh: chordamesoderm), Sox3 (neurectoderm) and Sox17a
(endoderm) (Fig. 5a–x). Expression of all six genes was reduced in
embryos injected with MOs targeting XtEMSY, although their
spatial expression patterns appeared normal. Of the genes exam-
ined, Chd and Shh were the most significantly downregulated,
suggesting that notochord formation is impaired, consistent with
the impairment of axial development observed above.
These results were confirmed by real-time RT-PCR, which
revealed that embryos injected with XtEMSY MO1 have reduced
levels of Xbra, Chordin, Goosecoid and Sonic hedgehog (Fig. 5y).
Downregulation of EMSY causes an elevation of p53 expression
EMSY was discovered in a screen for BRCA2 interactors and it links
the BRCA2 pathway to sporadic breast and ovarian cancer [1]. It
also localises to g-H2AX foci following radiation-induced double-
strand DNA breaks. Bearing these observations in mind, we used
whole mount in situ hybridisation to examine the expression of
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FIGURE 5
Expression of various regional markers is down regulated in embryos injected with XtEMSY MO1. (a–x) The expression patterns of the indicated genes at gastrula
and tailbud stages in control embryos and embryos injected with XtEMSY MO1. Note the impairment of gastrulation and the downregulation of, particularly, Shh
(m–p). The spatial expression patterns of the analysed genes are only slightly affected. (y) Real-time RT-PCR shows that expression of Xbra and Chd is slightly
decreased by loss of XtEMSY function, while expression of Gsc and Shh is down regulated more strongly.
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FIGURE 6
Loss of XtEMSY function causes upregulation of p53. (a and b) In situ
hybridisation analysis at the late neurula stage reveals that p53 is upregulated
in embryos injected with XtEMSY MO1 (b) compared with controls. (c)
Temporal RT-PCR analysis of p53 and Bax expression in embryos injected with
XtEMSY MO1. Expression levels are normalised to those of ornithine
decarboxylase and levels in control MO injected embryos are defined as
100%. Note that expression of p53 is elevated between stages 18 and 24 (dark
blue), while Bax is upregulated slightly later than this.
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Apoptosis in embryos injected with XtEMSYMO1. Control embryos (a and b) or em
No apoptosis was detected at stage 11 (a and b), but apoptotic cells were prese
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XtEMSY antisense morpholino oligonucleotides and noted that
while cdc1, cdc2, Rb1, Rb2 and Rad51 remained unchanged, p53
was upregulated in such embryos during gastrula and neurula
stages (Fig. 6a,b and data not shown). This conclusion was con-
firmed by real-time RT-PCR, although a substantial upregulation of
p53 was not noted until after stage 18 (Fig. 6c). p53 interacts with
the Smad signal transduction pathway downstream of TGF-b
family members; its over-expression in isolated animal pole
regions activates mesodermal and mesendodermal genes such as
Xhox3 andMix.1/2, while loss of p53 in the intact embryo inhibits
mesoderm formation [13–15]. Together, these observations make
it unlikely that the loss of mesodermal markers observed in
embryos injected with XtEMSY antisense morpholino oligonu-
cleotides (Fig. 5) is a direct consequence of the modulation of p53,
and indeed we find that we cannot rescue the effects of XtEMSY
MO1 by means of an antisense morpholino oligonucleotide tar-
geted against X. tropicalis p53 (data not shown).
Upregulation of p53 in embryos lacking XtEMSY is followed by
upregulation of Bax and by apoptosis
Although p53 upregulation is unlikely to influence directly the
decrease in expression of genes such as Gsc and Shh, we note that
expression of the apoptosis associated gene Bax [16] is also upre-
gulated in embryos injected with XtEMSY MO1 (Fig. 6c). Consis-
tent with this observation, TUNEL staining of embryos injected
with XtEMSY MO1 reveals that apoptotic cells can be detected
from late neurula to tailbud stages, with a particular concentration
in dorsal tissues (Fig. 7).
Discussion
XtEMSY, the orthologue of human EMSY, is expressed as a short
isoform during early development of X. tropicalis and is co-
expressed with genes encoding proteins that interact with itsbryos injected with XtEMSYMO1 (c and d)were subjected to TUNEL staining.
nt by tailbud stages in dorsal regions (c and d).
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transcriptional regulation, chromatin remodelling and DNA
repair.
Loss of EMSY function in X. tropicalis disrupts gastrulation and
axial development. Expression of the regional markers Xbra, Chd,
Gsc, Shh, Sox3 and Sox17a is reduced at gastrula and tailbud stages,
although their spatial expression patterns are little affected. In
contrast, p53 is upregulated during gastrula stages, as is Bax at
neurula stages. The upregulation of these genes may underlie the
apoptosis observed in XtEMSY knockdown embryos [16]. It is
unlikely, however, that the upregulation of p53 or Bax disrupts
gastrulation or causes the loss of regional markers, because expres-
sion of the two genes increases only after these phenotypes are
detectable, and injection of an antisense morpholino oligonucleo-
tide directed against X. tropicalis p53 cannot rescue the embryos.
Furthermore, upregulation of p53 activates the expression of meso-
dermal markers rather than inhibiting their transcription [14,15].
Using our current study as a platform, in future work we will
aim to investigate XtEMSY function in the spatio-temporal
control of gene transcription including epigenetic regulation
and epigenomic remodelling (determining cell fate in this case)
versus its role in replication, similar to Polycomb protein groupprotein-containing complexes, which modulate whether chro-
matin is in a closed or open state (in conjunction with Top2)
independently from their role in replication (in conjunction
with Top1). This type of work is usually only addressed in
studies based on cell lines, addressing in this case ‘stem cell-
ness’, transit amplification and differentiation. However
through our initial characterisation we have the first opportu-
nity to take this type of analysis in vivo.
Finally this work also demonstrates the usefulness of the Xeno-
pus morphant system as a technique for discovering the potential
functions of genes found in mammals for which the loss-of-func-
tion models yield no obvious phenotype.
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